|
We do not use heparin, but if we did we would probably wait until after the procedure and use a marked pre-filled syringe. We draw up the NS in two syringes, and the lidocaine in another, and immediately attach the SQ needle to the lidocaine syringe as soon as it is filled.
Leigh Ann
Leigh Ann Bowe-Geddes, RN, CRNI
IV Therapy Specialist Infusion Services Department University of Louisville Hospital Louisville, KY 502-562-3530 >>> "Wendy Boersma" <[EMAIL PROTECTED]> 11/03/05 8:16 AM >>> JACHO has blessed us with another survey as I speak. One thing that was
strongly pointed out is that all medications will need to be labeled on our syringes or a process identifying the different medications when on our sterile field. I guess I am asking what others approach will be to this. In our Cath Lab they have color coded syringes and this was acceptable to the Physician surveyor but the manufacturer I use does not have labels or color coded syringes in the tray that we are currently using. What will be everyone's approach to this. Our process currently is we use a small syringe and this is the Lidocaine. We attach our saline syringe immediately to the catheter when drawn up and our Heparin is on the right side of our field. Thanks for your input in advance. Wendy Boersma, RN, BSN, CRNI Infusion Therapy Services Coordinator 269-966-8591 or pager 269-410-0385 This message may contain confidential information protected by law through attorney-client privilege or professional peer review/quality evaluation privilege. It is intended only for the individual or entity named above. It is prohibited for anyone else to disclose, copy, distribute or use the contents of this message. If you received this message in error, please notify the BCHS Privacy/Integrity Office at [EMAIL PROTECTED] or (269)966-8017.
This
message, including any attachments, is confidential, intended only for the named
recipient(s) and may contain information that is privileged or exempt from
disclosure under applicable law, including PHI (Protected Health Information)
covered under the Health Insurance Portability and Accountability Act (HIPAA) of
1996. If you are not the intended
recipient(s), you are notified that the dissemination, distribution, or copying
of this message is strictly prohibited. If
you receive this message in error, or are not the named recipient(s), please
notify the sender or contact the University of Louisville Health Care I.S.
helpdesk at 502.562.3637 to report an inadvertently received message.
----------------------------------------------------- |
- Attention Manufacturers Wendy Boersma
- Re: Attention Manufacturers Leigh Ann Bowe-geddes
- Re: Attention Manufacturers Nanette Richards
- RE: Attention Manufacturers Beverly Moore
- RE: Attention Manufacturers Kokotis, Kathy
- RE: Attention Manufacturers Lynn Hadaway
- RE: Attention Manufacturers Nicastro, Margaret
- RE: Attention Manufacturers Dianne Sim
- RE: Attention Manufacturers Ann . Zonderman
- RE: Attention Manufacturers Lynn Hadaway
- RE: Attention Manufacturers Lynn Hadaway
- RE: Attention Manufacturers Gail McCarter
